Nuclear cardiology techniques in atrial fibrillation (review)
https://doi.org/10.15829/1560-4071-2025-6707
EDN: DQEYMG
Abstract
This paper analyzes Russian and international literature to determine the diagnostic efficacy of radioisotope methods with various radiopharmaceuticals in patients with atrial fibrillation (AF).
We search for publications in PubMed and Elibrary databases covering the period 20002025 focused on the use of radioisotope methods with various radiopharmaceuticals. This review highlights the potential of radioisotope diagnostic methods such as singlephoton emission computed tomography and positron emission tomography with various radiopharmaceuticals in patients with AF. The diagnostic and prognostic aspects of radioisotope technologies for persistent and paroxysmal atrial fibrillation are discussed. The contribution of [123I]-MIBG scintigraphy in planning interventional treatment for AF is noted. Radioisotope imaging makes a significant contribution to diagnosing the causes of arrhythmia and has prognostic value in predicting adverse events and treatment effectiveness.
About the Authors
D. V. Ryzhkova
Almazov National Medical Research Center
Russian Federation
Russian Federation
Akkuratova str., 2, St. Petersburg, 197341
O. V. Karpova
Almazov National Medical Research Center
Russian Federation
Russian Federation
Akkuratova str., 2, St. Petersburg, 197341
References
1. Ryzhkova DV, Nifontov EM, Tyutin LA. Positron emission tomography application for myocardial blood flow and coronary flow reserve measurement in patients with cardiovascular pathology. Arter gipertenz. 2006;12(3):200-11. doi:10.18705/1607-419X2006-12-3-200-211.
2. Miller TD, Askew JW. Radionuclide Imaging for Assessment of Patients with Atrial Fibrillation. European Cardiology Review. 2009;5(1):20. doi:10.15420/ECR.2009.5.1.20.
3. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Journal of the American College of Cardiology. 2003;42(7):1318- 33. doi:10.1016/j.jacc.2003.08.011.
4. Askew JW, Miller TD, Hodge DO, et al. The value of myocardial perfusion single-photon emission computed tomography in screening asymptomatic patients with atrial fibrillation for coronary artery disease. Journal of the American College of Cardiology. 2007;50(11):1080-5. doi:10.1016/j.jacc.2007.05.035.
5. Abidov A, Hachamovitch R, Rozanski A, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography. Journal of the American College of Cardiology. 2004;44(5):1062-70. doi:10.1016/j.jacc.2004.05.076.
6. Range FT, Schafers M, Acil T, et al. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. European Heart Journal. 2007;28(18):2223-30. doi:10.1093/eurheartj/ehm246.
7. Cremer PC, Mentias A, Newton D, et al. Low Yield of Myocardial Perfusion Imaging in Asymptomatic Patients With Atrial Fibrillation. JAMA Intern Med. 2015;175(11):1854. doi:10.1001/jamainternmed.2015.4802.
8. Smit MD, Tio RA, Slart RHJA, et al. Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation. Europace. 2010;12(5):643-8. doi:10.1093/europace/eup404.
9. Bechlioulis A, Rammos A, Papadopoulos A, et al. Atrial Fibrillation as an Independent Predictor of Myocardial Ischemia. Medicina. 2025;61(2):337. doi:10.3390/medicina61020337.
10. Byrne C, Hasbak P, Kjær A, et al. Myocardial perfusion during atrial fibrillation in patients with non-ischaemic systolic heart failure: a cross-sectional study using Rubidium 82 positron emission tomography/computed tomography. European Heart Journal — Cardiovascular Imaging. 2019;20(2):233-40. doi:10.1093/ehjci/jey089.
11. Range FT, Paul M, Schäfers KP, et al. Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation. J Nucl Med. 2009;50(3):390-6. doi:10.2967/jnumed.108.055665.
12. Gimelli A, Liga R, Startari U, et al. Evaluation of ischaemia in patients with atrial fibrillation: impact of stress protocol on myocardial perfusion imaging accuracy. European Heart Journal — Cardiovascular Imaging. 2015;16(7):781-7. doi:10.1093/ehjci/jeu322.
13. Zhou X, Dudley SC. Evidence for Inflammation as a Driver of Atrial Fibrillation. Front Cardiovasc Med. 2020;7:62. doi:10.3389/fcvm.2020.00062.
14. Lal M, Chen C, Newsome B, et al. Genetic Cardiomyopathy Masquerading as Cardiac Sarcoidosis. Journal of the American College of Cardiology. 2023;81(1):100-2. doi:10.1016/j.jacc.2022.10.021.
15. Nakamura O, Goetz C, Meyer PT, et al. Increased 18F-fluorodeoxyglucose uptake in the cardiac atria: an evidence for increased atrial inflammation in patients with atrial fibrillation? EP Europace. 2022;24(Supplement_1): euac053.599. doi:10.1093/europace/euac053.599.
16. Kupusovic J, Weber M, Kessler L, et al. Increased FDG uptake in AF individuals suggesting atrial inflammation visualized by FDG PET/CT with glucose uptake suppression protocols. European Heart Journal. 2021;42(Supplement_1):ehab724.0324. doi:10.1093/eurheartj/ehab724.0324.
17. Nattel S, Burstein B, Dobrev D. Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications. Circ: Arrhythmia and Electrophysiology. 2008;1(1):62-73. doi:10.1161/CIRCEP.107.754564.
18. Wang B, Xu Y, Wan P, et al. Right Atrial Fluorodeoxyglucose Uptake Is a Risk Factor for Stroke and Improves Prediction of Stroke Above the CHA2DS2-VASc Score in Patients With Atrial Fibrillation. Front Cardiovasc Med. 2022;9:862000. doi:10.3389/fcvm.2022.862000.
19. Sinigaglia M, Mahida B, Piekarski E, et al. FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation. Eur J Nucl Med Mol Imaging. 2019;46(6):1268-75. doi:10.1007/s00259-019-4274-6.
20. Wan P, Wang B, Yu W, et al. Right atrial wall inflammation detected by 18F-FDG PET/CT may be significantly associated with persistent atrial fibrillation: a prospective case-control study. BMC Cardiovasc Disord. 2023;23(1):587. doi:10.1186/s12872-023-03592-2.
21. Kassar A, Chamoun N, Haykal R, et al. Atrial FDG uptake and atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm O2. 2025;6(4):417-23. doi:10.1016/j.hroo.2025.01.002.
22. Li L, Gao J, Chen BX, et al. Fibroblast activation protein imaging in atrial fibrillation: a proofof-concept study. J Nucl Cardiol. 2023;30(6):2712-20. doi:10.1007/s12350-023-03352-x.
23. Minin S, Nikitin N, Pokushalov E, et al. Possibilities of single-photon emission computed tomography for the assessment of cardiac global and regional sympathetic activity in patients with atrial fibrillation. PKiK. 2019;23(3):57-64. doi:10.21688/1681-3472-2019-3-57-64.
24. Ansheles AA, Sergienko VB. Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography. Vestn rentgenol radiol. 2016;(3):173-80. doi:10.20862/0042-4676-2016-97-3-173-180.
25. Akutsu Y, Kaneko K, Kodama Y, et al. Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation. Eur J Nucl Med Mol Imaging. 2010;37(4):742-9. doi:10.1007/s00259-009-1322-7.
26. Akutsu Y, Kaneko K, Kodama Y, et al. Iodine 123 mIBG Imaging for Predicting the Development of Atrial Fibrillation. JACC: Cardiovascular Imaging. 2011;4(1):78-86. doi:10.1016/j.jcmg.2010.10.005.
27. Arimoto T, Tada H, Igarashi M, et al. High Washout Rate of Iodine 123-Metaiodobenzylguanidine Imaging Predicts the Outcome of Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2011;22(12):1297-304. doi:10.1111/j.1540-8167.2011.02123.x.
28. Wenning C, Lange PS, Schülke C, et al. Pulmonary vein isolation in patients with paroxysmal atrial fibrillation is associated with regional cardiac sympathetic denervation. EJNMMI Res. 2013;3(1):81. doi:10.1186/2191-219X-3-81.
29. Popov SV, Batalov RE, Kisteneva IV, et al. A method for predicting the effectiveness of catheter treatment of atrial fibrillation based on an assessment of the dynamics of sympathetic and parasympathetic tone of the autonomic nervous system of the myocardium. Tomsk 2016. pp:1-6. (In Russ.) ISBN: 978- 5-6040497-2-3.
30. Nikitin NA, Minin SM, Shabanov VV, et al. Possibilities of Hybrid SPECT/CT with 123I-MIBG for Visualizing the Ganglia of the Cardiac Autonomic Nervous System in Healthy Volunteers. Vestn rentgenol radiol. 2020;100(6):314-20. doi:10.20862/0042-4676-2019-100-6-314-320.
31. Pauza DH, Skripka V, Pauziene N, et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259(4):353- 82. doi:10.1002/1097-0185(20000801)259:4%3C353::AID-AR10%3E3.0.CO;2-R.
32. Po SS, Nakagawa H, Jackman WM. Localization of Left Atrial Ganglionated Plexi in Patients with Atrial Fibrillation. Cardiovasc electrophysiol. 2009;20(10):1186-9. doi:10.1111/j.1540-8167.2009.01515.x.
33. Pokushalov E, Romanov A, Artyomenko S, et al. Left Atrial Ablation at the Anatomic Areas of Ganglionated Plexi for Paroxysmal Atrial Fibrillation: left atrial ablation of ganglionated plexi. Pacing and Clinical Electrophysiology. 2010;33(10):1231-8. doi:10.1111/j.1540-8159.2010.02800.x.
34. Kurotobi T, Shimada Y, Kino N, et al. Features of intrinsic ganglionated plexi in both atria after extensive pulmonary isolation and their clinical significance after catheter ablation in patients with atrial fibrillation. Heart Rhythm. 2015;12(3):470-6. doi:10.1016/j.hrthm.2014.11.033.
35. Stirrup J, Gregg S, Baavour R, et al. Hybrid solid-state SPECT/CT left atrial innervation imaging for identification of left atrial ganglionated plexi: Technique and validation in patients with atrial fibrillation. Journal of Nuclear Cardiology. 2020;27(6):1939-50. doi:10.1007/s12350-018-01535-5.
- Radioisotope diagnostic techniques allow for the assessment of the anatomical and topographical cardiac characteristics, coronary microcirculation disorders, cardiac metabolism and innervation, and the location of atrial ganglionated plexuses within a single study.
Review
For citations:
Ryzhkova D.V., Karpova O.V. Nuclear cardiology techniques in atrial fibrillation (review). Russian Journal of Cardiology. 2025;30(4S):6707. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6707. EDN: DQEYMG
Views:
110
JATS XML
Email this article 